IN THE SPOTLIGHT

Types of Lung Cancer: Knowing the Differences and Treatment Options

Types of Lung Cancer: Knowing the Differences and Treatment Options

Current knowledge of small cell lung cancer transformation from non-small cell lung cancer

Current knowledge of small cell lung cancer transformation from non-small cell lung cancer

Some patients with small-cell lung cancer can benefit from PARP inhibitor with immune checkpoint blockade

Some patients with small-cell lung cancer can benefit from PARP inhibitor with immune checkpoint blockade

SCLC: Bispecific antibody shows phase 1 promise

SCLC: Bispecific antibody shows phase 1 promise

Patients With SLFN11-Expressing SCLC May Benefit From Immune Checkpoint Inhibitor Plus PARP Inhibitor

Patients With SLFN11-Expressing SCLC May Benefit From Immune Checkpoint Inhibitor Plus PARP Inhibitor

New Study Confirms Consistent Risk of Myelosuppression Across All Patients Receiving Chemotherapy for Small Cell Lung Cancer

New Study Confirms Consistent Risk of Myelosuppression Across All Patients Receiving Chemotherapy for Small Cell Lung Cancer

Room to Grow in the Small Cell Lung Cancer Treatment Landscape

Room to Grow in the Small Cell Lung Cancer Treatment Landscape

Foundation Medicine to Share 10 Abstracts at AACR23 Demonstrating the Unique Capabilities of Its Molecula

Foundation Medicine to Share 10 Abstracts at AACR23 Demonstrating the Unique Capabilities of Its Molecula

Discussing When to Use Durvalumab in SCLC

Discussing When to Use Durvalumab in SCLC

Bispecific Antibody Active in Relapsed/Refractory Small Cell Lung Cancer

Bispecific Antibody Active in Relapsed/Refractory Small Cell Lung Cancer